These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 19249515

  • 1. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
    Avolio AW, Frongillo F, Nicolotti N, Mulè A, Vennarecci G, De Simone P, Agnes S.
    Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
    [Abstract] [Full Text] [Related]

  • 2. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA.
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [Abstract] [Full Text] [Related]

  • 3. Assignment of steatotic livers by the Mayo model for end-stage liver disease.
    Briceño J, Padillo J, Rufián S, Solórzano G, Pera C.
    Transpl Int; 2005 May; 18(5):577-83. PubMed ID: 15819807
    [Abstract] [Full Text] [Related]

  • 4. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.
    de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, Pleass H, Crawford M, McCaughan GW, Verran DJ.
    J Gastroenterol Hepatol; 2012 Mar; 27(3):540-6. PubMed ID: 21777274
    [Abstract] [Full Text] [Related]

  • 5. Expanding postmortem donor pool using steatotic liver grafts: a new look.
    Noujaim HM, de Ville de Goyet J, Montero EF, Ribeiro CM, Capellozzi VL, Crescentini F, Casagrande M, Santos RG, Curvello L, de Miranda MP, Genzini T.
    Transplantation; 2009 Mar 27; 87(6):919-25. PubMed ID: 19300197
    [Abstract] [Full Text] [Related]

  • 6. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival.
    Frongillo F, Avolio AW, Nure E, Mulè A, Pepe G, Magalini SC, Agnes S.
    Transplant Proc; 2009 May 27; 41(4):1268-72. PubMed ID: 19460535
    [Abstract] [Full Text] [Related]

  • 7. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.
    Liver Transpl; 2009 Jun 27; 15(6):619-28. PubMed ID: 19479805
    [Abstract] [Full Text] [Related]

  • 8. Donor liver dysfunction: application of a new scoring system to identify the marginal donor.
    Ferraz-Neto BH, Zurstrassen MP, Hidalgo R, Fonseca LE, Motta TD, Pandullo FL, Rezende MB, Meira-Filho SP, Sá JR, Afonso RC.
    Transplant Proc; 2007 Oct 27; 39(8):2516-8. PubMed ID: 17954162
    [Abstract] [Full Text] [Related]

  • 9. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, Stewart G, McCaughan G.
    Liver Transpl; 2003 May 27; 9(5):500-5. PubMed ID: 12740794
    [Abstract] [Full Text] [Related]

  • 10. Feasibility of reduced-size orthotopic liver transplantation with fatty grafts and its potential regeneration in rats.
    Sheng Y, Jiahong D, Benli H.
    Arch Med Res; 2009 Apr 27; 40(3):146-55. PubMed ID: 19427964
    [Abstract] [Full Text] [Related]

  • 11. Extended criteria donors in liver transplantation: adapting donor quality and recipient.
    Gastaca M.
    Transplant Proc; 2009 Apr 27; 41(3):975-9. PubMed ID: 19376402
    [Abstract] [Full Text] [Related]

  • 12. Impact of steatotic grafts on initial function and prognosis after liver transplantation.
    Afonso RC, Saad WA, Parra OM, Leitão R, Ferraz-Neto BH.
    Transplant Proc; 2004 May 27; 36(4):909-11. PubMed ID: 15194312
    [Abstract] [Full Text] [Related]

  • 13. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y, Shimada M, Suehiro T, Kishikawa K, Yoshizumi T, Hashimoto K, Minagawa R, Hiroshige S, Terashi T, Ninomiya M, Shiotani S, Harada N, Sugimachi K.
    Transplantation; 2003 Jul 27; 76(2):344-8. PubMed ID: 12883190
    [Abstract] [Full Text] [Related]

  • 14. Contribution of marginal donors to liver transplantation for hepatitis C virus infection.
    Briceño J, Ciria R, Pleguezuelo M, Naranjo A, Sánchez-Hidalgo J, Ruiz-Rabelo J, López-Cillero P, Luque A, de la Mata M, Rufián S.
    Transplant Proc; 2007 Sep 27; 39(7):2297-9. PubMed ID: 17889169
    [Abstract] [Full Text] [Related]

  • 15. Reversal of graft steatosis after liver transplantation: prospective study.
    Li J, Liu B, Yan LN, Zuo YX, Li B, Zeng Y, Zhang SF, Li FG.
    Transplant Proc; 2009 Nov 27; 41(9):3560-3. PubMed ID: 19917344
    [Abstract] [Full Text] [Related]

  • 16. The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation.
    Cho JY, Suh KS, Kwon CH, Yi NJ, Cho SY, Jang JJ, Kim SH, Lee KU.
    Liver Transpl; 2005 Feb 27; 11(2):210-7. PubMed ID: 15666394
    [Abstract] [Full Text] [Related]

  • 17. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan 27; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

  • 18. Using elderly donors in liver transplantation.
    Grazi GL, Ravaioli M, Zanello M, Ercolani G, Cescon M, Varotti G, Del Gaudio M, Vetrone G, Lauro A, Ramacciato G, Pinna AD.
    Transplant Proc; 2005 Jan 27; 37(6):2582-3. PubMed ID: 16182750
    [Abstract] [Full Text] [Related]

  • 19. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors.
    Wong TC, Fung JY, Chok KS, Cheung TT, Chan AC, Sharr WW, Dai WC, Chan SC, Lo CM.
    Liver Transpl; 2016 Feb 27; 22(2):226-36. PubMed ID: 26359934
    [Abstract] [Full Text] [Related]

  • 20. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era.
    Briceño J, Ciria R, de la Mata M, Rufián S, López-Cillero P.
    Transplantation; 2010 Sep 15; 90(5):530-9. PubMed ID: 20581766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.